JeffreyWeitzelMD

Professor of Oncology and Population Sciences Dr. Norman & Melinda Payson Professorship in Medical Oncology Founder, Division of Clinical Cancer Genomics City of Hope Cancer Center 1500 East Duarte Road Duarte, CA 91010

Join to view full profile

Dr. Weitzel is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Weitzel's full profile

Already have an account?

Office
4000 Cambridge St
Kansas City, KS 66160
Phone+1 913-588-6656

Education & Training

Tufts Medical CenterFellowship, Medical Genetics and Genomics, 1994 - 1996
Tufts Medical CenterFellowship, Hematology and Medical Oncology, 1987 - 1992
University of MinnesotaResidency, Internal Medicine, 1983 - 1986
University of Minnesota Medical SchoolClass of 1983

Certifications & Licensure

CA State Medical License 1996 - 2026
KS State Medical License 2024 - 2025
MN State Medical License 1985 - 2025
AZ State Medical License 2000 - 2015
MA State Medical License 1986 - 1997
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

Conquer Cancer Research Professorship in Breast Cancer Disparities ASCO Conquer Cancer Foundation
America's Top Doctors Castle Connolly, 2004-2020
American Society of Human Genetics Arno Motulsky-Barton Childs Award for Excellence in Human Genetics Education American Society of Human Genetics, 2019
Top Doctors:LA Area Castle Connolly, 2013
America's Top Doctors for Cancer Castle Connolly, 2005-2013
Top Doctors:Southern California Castle Connolly, 2012
Join now to see all

Clinical Trials

Deslorelin Combined With Low-Dose Add-Back Estradiol and Testosterone in Preventing Breast Cancer in Premenopausal Women Who Are at High Risk for This Disease Start of enrollment: 2004 Mar 11
Active, not recruiting
Phase 2
Veliparib With or Without Carboplatin in Treating Patients With Stage III or IV Breast Cancer Start of enrollment: 2010 Jun 30
Active, not recruiting
Phase 2
Culturally-Informed Counseling in Latinas at High Risk for Hereditary Breast or Ovarian Cancer Start of enrollment: 2010 Sep 03
Active, not recruiting
Not Applicable
Molecular Genetics Studies of Cancer Patients and Their Relatives Start of enrollment: 1997 Apr 18
Recruiting
Roles: Contact, Principal Investigator
Join now to see all

Publications & Presentations

PubMed

395 citations
Beyond Li Fraumeni Syndrome: Clinical Characteristics of Families With p53 Germline Mutations
Kelly D. Gonzalez, Katie Noltner, Carolyn H. Buzin, Dongqing Gu, Cindy Y. Wen-Fong
Journal of Clinical Oncology. 2009-03-10
119 citations
Breast cancer phenotype in women with TP53 germline mutations: a Li-Fraumeni syndrome consortium effort
Serena Masciari, Deborah A. Dillon, Michelle G. Rath, Mark E. Robson, Jeffrey N. Weitzel
Breast Cancer Research and Treatment. 2012-03-04
53 citations
Analysis of the Li-Fraumeni Spectrum Based on an International Germline TP53 Variant Data Set: An International Agency for Research on Cancer TP53 Database Analysis
Christian P. Kratz, Claire Freycon, Kara N. Maxwell, Kim E. Nichols, Joshua D. Schiffman
JAMA Oncology. 2021-10-28

Lectures

Finding a Germline Mutation During Tumor Testing: Implications for the Patient and the Family
2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018

Press Mentions

Gov. Newsom Should Release Vulnerable PrisonersJuly 8th, 2020
City of Hope Physicians Present Innovative Cancer Research at ASCO20 Virtual SessionMay 30th, 2020
City of Hope to Lead National Research Aimed at Improving testing/treatment for Devastating Cancer-Causing SyndromeNovember 22nd, 2019
Join now to see all